AbbVie Inc.
NYSE:ABBV:US
Featured Articles and Interviews
Feb 11, 2025
What is In-Licensing?
Jan 16, 2025
What are Dividend Stocks?
More Featured Articles and Inverviews
Press Releases
More Press Releases
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Interactive Chart
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â